The Jockey Club School of Public Health and Primary Care (JCSPHPC) is pleased to co-host “A workshop on health economics in policy and practice” with The George Institute for Global Health, Australia. This is a half day workshop on the use of health economic evaluation in health sector decision making. It is a non-technical course for policy makers, health sector managers, clinicians, researchers in health and medical related fields, industry and non-government organisations involved in the delivery of health sector programs (e.g., consumer groups). It will provide participants with a general understanding of the role of economic evaluation in the health sector and will include case studies and critical appraisal. The specific objectives of the workshop are:
To provide a basic grounding in economics and economic evaluation concepts
To enable individuals to critically appraise economic evaluation evidence and understand its strengths and limitations.
To provide guidance for decision makers on how to engage with health economists to develop an investment case and present examples of economic evaluation in practice and policy (e.g., Health Technology Assessment, Social Impact Bonds).
The workshop will be run by Professor Stephen Jan from the George Institute for Global Health, an economist with over 25 years of experience in health economics and health systems research and teaching.
Workshop details:
Date: | 16 September, 2024 (Monday) |
Time: | 9am – 3pm (HKT) |
Venue: | LT1A, Cheng Yu Tung Building, The Chinese University of Hong Kong |
Fee: | Free of charge (registration is open on a first-come-first-served basis) |
Speaker: | Professor Stephen JAN Program Director of Health Systems Science, The George Institute for Global Health |
Facilitator: | Professor Benjamin YIP Associate Professor, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong |
Programme rundown:
Time | Session |
08:30 – 09:00 | Registration |
09:00 – 09:15 | Welcome and introductions |
09:15 – 10:15 | Introduction to key concepts in economics and economic evaluation |
10:15 – 10:30 | Reflection and questions |
10:30 – 10:45 | Break |
10:45 – 11:45 | Practical issues in economic evaluation (e.g., trial vs modelled economic evaluation, discounting, costing, quality of life valuation) |
5-minute break | |
11:50 – 12:30 | Case studies |
12:35 – 13:35 | Lunch |
13:35 – 14:15 | Economic evaluation in policy and practice |
14:15 – 14:45 | Open discussion: how do we achieve impact with economic evaluation evidence on clinical practice and health policy? |
14: 45 – 15:00 | Closing |
About the Speaker
Prof Stephen Jan is Program Director of Health Systems Science at the George Institute for Global Health, Conjoint Professor of Health Economics at the University of New South Wales, and a Fellow of the Australian Academy of Health and Medical Sciences. He is a visiting researcher at the Centre for Health Economics Policy Innovation at the Business School, Imperial College London and Adjunct Professor at the Department of Public and International Affairs, City University of Hong Kong.
His areas of expertise are economic evaluation, health financing, health sector priority setting, Indigenous and global health issues. He was a member of the Lancet Taskforce on Non-Communicable Diseases and Economics. He has published over 350 scientific papers and led numerous studies around the household economic impact of non-communicable diseases including ACTION (8000+ patients cancer in SE Asia), EPICOR-Asia economic sub-study (11,000+ patient with heart disease in Asia) and VISIONARY (400+ patients with cataract in Vietnam). He has worked with governments, both in Australia and overseas, and with international agencies such as the WHO, NCD Alliance and industry and has served as on the Board of Directors of the Sax Institute, a non-profit research organisation in Sydney.
About the Facilitator
Prof Benjamin Yip is currently Associate Professor at JC School of Public Health and Primary Care, The Chinese University of Hong Kong. Dr. Yip has pioneered the development and application of genetic epidemiological models to disentangle the genetic and environmental underpinnings of various diseases. His early works resolved a longstanding debate in psychiatry by demonstrating substantial genetic etiological overlap between schizophrenia and bipolar disorder. Building on this foundation, Dr. Yip led heritability estimations for autism spectrum disorder (ASD) across five nations, affirming the high heritability of ASD. He is participating in the SFARI Sex Differences Collaborations Project, aiming to unravel the reasons behind the higher incidence of ASD in males compared to females. He has critically examined the widely accepted female protective effect hypothesis and proposed an alternative genetic epidemiological model to account for the observed sex disparities in ASD prevalence. Dr. Yip's contributions have been recognized through publication in prestigious journals, including The Lancet, JAMA Psychiatry, Biological Psychiatry, and Molecular Psychiatry, among others.
His secondary research focus lies in clinical epidemiology, where he actively engages in cross-disciplinary collaborations in clinical trials. As the principal biostatistician of 21 trials, he has directed trial designs, developed analytical plans, and executed effectiveness and cost-effectiveness analyses. Dr. Yip has a h-index of 31 (Mar 2024) and the Principal Investigator (PI) or Co-Principal Investigator (Co-PI) on 37 competitive grants, amassing a total of HK$120 million in research funding.
Comments